학술논문

Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis regardless of prior treatment failures.
Document Type
Article
Source
Journal of the Neurological Sciences. 2023 Supplement, Vol. 455, pN.PAG-N.PAG. 1p.
Subject
*MYASTHENIA gravis
*TREATMENT failure
Language
ISSN
0022-510X